⌘K
Loading ticker…
As of 2026-08-21, Medical Properties Trust, Inc. (MPT) has a 3-month relative strength percentile of 19 within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 49.9 (Neutral). Sector: Financials, ranked 6 of 11. Average daily range 3.4%, relative volume 0.82×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Not enough history to compute monthly seasonality for MPT.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
MPT is held by 24 ETFs as of May 2026. Top owner: SCHH at 0.18% weight, $18M notional. Top 3 carry $47M.
Held by 74 ETFs · $596M across latest filings · largest weight 0.93% (RFDA).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHH | 0.18% | $18M | −0.02 pp |
| FNDA | 0.20% | $18M | −0.05 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.05% | $12M | −0.01 pp |
| VIOOVanguard S&P Small-Cap 600 ETF | 0.15% | $9M | −0.03 pp |
| VIOVVanguard S&P Small-Cap 600 Value ETF | 0.29% | $6M | −0.07 pp |
| BBRE | 0.31% | $4M | −0.04 pp |
| VONVVanguard Russell 1000 Value ETF | 0.01% | $2M | — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $2M | — |
| RWJ | 0.06% | $1M | — |
| EQAL | 0.14% | $1M | −0.01 pp |
Showing 10 of 24 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches